Medibank share price on watch amid class action and new data threat

Medibank shares closed in the green yesterday after the ASX 200 health insurer updated the market on its response to the October cyber breach.

| More on:
A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Medibank share price is on watch
  • The ASX 200 insurer has been hit with a class action over the October data breach
  • Yesterday Medibank said it would not make any ransom payments

The Medibank Private Ltd (ASX: MPL) share price is on watch this morning.

This comes as news hits the wires that the S&P/ASX 200 Index (ASX: XJO) health insurer has been hit with a class action over the 12 October data breach.

Yesterday the Medibank share price finished up 0.4% after the company updated the market on its response to the data theft.

The company said the hacker had accessed the name, date of birth, address, phone number and email address of 9.7 million current and former customers along with some of their authorised representatives.

That group includes  5.1 million Medibank customers, 2.8 million AHM customers and 1.8 million international customers.

Medibank said it would not pay any ransom demands.

According to CEO David Koczkar:

Based on the extensive advice we have received from cybercrime experts we believe there is only a limited chance paying a ransom would ensure the return of our customers' data and prevent it from being published.

Today the company faces its first, but perhaps not last, class action over the incident.

This comes alongside news that the hackers have threatened to publish the customer data within 24 hours.

What's happening with the Medibank class action?

The Medibank share price is on watch after Bannister Law Class Actions and Centennial Lawyers reported they will jointly investigate the cyber breach.

In a statement released this morning, Bannister said (courtesy of The Sydney Morning Herald):

We believe the data breach is a betrayal of Medibank Private's customers and a breach of the Privacy Act. Medibank has a duty to keep this kind of information confidential.

The two firms will be investigating Medibank breached their privacy policy and the terms of their contract of the medical insurance which they provided to their customers. The lawyers will also assess whether damages should be paid to Medibank customers as a result of their breaches.

Medibank share price snapshot

The Medibank share price has come under significant pressure since the hacking attack was revealed. Shares are currently down 17.5% in 2022. That compares to an 8.6% year-to-date loss posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »